dupilumab
sanofi,regeneron
['dupilumab', 'dupixent']
dupixent (dupilumab) late-breaking data at aad show - globenewswire at 16 weeks, patients treated with dupixent experienced the following: ... with other asthma medicines for the maintenance treatment of ...
#TheAsthmaCures https://t.co/vRkYeArZWg helping those with chronic #asthma https://t.co/7SMiyxzFdG resolving https://t.co/nIlzNga34W https://t.co/T67YXQ3eBZ